ne thames regional genetics service annual report thames... · north east thames regional genetics...
TRANSCRIPT
NE Thames Regional Genetics Service Annual Report
2010-2011 Great Ormond Street Hospital NHS Trust
North East Thames Regional Genetics Service Annual Report
Page 1
TABLE OF CONTENTS
EXECUTIVE SUMMARY......................................................................................................... 3
1. INTRODUCTION............................................................................................................ 4
2. CLINICAL GENETICS...................................................................................................... 5 2.1. Staff List ......................................................................................................................................... 5 2.2. General Clinics.............................................................................................................................. 7 2.3. Cancer Clinics ................................................................................................................................ 7 2.4. Specialist Clinics............................................................................................................................ 7 2.5. Activity............................................................................................................................................ 8 2.6. Transfer from Paper Records to Electronic Notes .................................................................. 9 2.7. Universal Newborn Screening Service – Cystic Fibrosis .....................................................10 2.8. Patient and Public Involvement ................................................................................................10
2.8.1. Genetics for Interpreters ..................................................................................................10 2.8.2. Patient Survey ....................................................................................................................10 2.8.3. Patient Information Evening - “Telling the Family about a Genetic Disorder”.......10
2.9. Training and Teaching...............................................................................................................11 2.10. Professional Duties .....................................................................................................................13
3. REGIONAL GENETICS LABORATORIES....................................................................... 15 3.1. Cytogenetics Service Staff List.................................................................................................15 3.2. Cytogenetics Service Activity ...................................................................................................17 3.3. New Service Developments ......................................................................................................18
3.3.1. Chromosomal Microarrays ...............................................................................................18 3.3.2. Automation of Cell Harvesting, Slide Making and Staining ......................................18 3.3.3. Solid Tissue Analysis ..........................................................................................................18
3.4. Quality..........................................................................................................................................18 3.5. Molecular Genetics Service Staff List .....................................................................................19 3.6. Molecular Genetics Service Activity........................................................................................20 3.7. New Service Developments ......................................................................................................21 3.8. Quality..........................................................................................................................................21 3.9. Continuing Professional Development ....................................................................................21
3.9.1. Modernising Scientific Careers........................................................................................21 3.9.2. Teaching...............................................................................................................................21 3.9.3. Meetings Attended ............................................................................................................22
3.10. Professional Duties .....................................................................................................................23
4. RESEARCH AND DEVELOPMENT ................................................................................ 24 4.1. RAPID (Reliable accurate prenatal non-invasive diagnosis) ..............................................24
4.1.1. Collection and Processing of Samples ...........................................................................24 4.1.2. Pilot EQA Scheme ..............................................................................................................24 4.1.3. Free Fetal DNA Extraction Workshop ...........................................................................24
North East Thames Regional Genetics Service Annual Report
Page 2
4.1.4. Diagnosis of Single Gene Disorders...............................................................................25 4.2. Next Generation Sequencing...................................................................................................25 4.3. Chromosomal Microarrays........................................................................................................25
5. PUBLICATIONS, ABSTRACTS & PRESENTATIONS....................................................... 26
North East Thames Regional Genetics Service Annual Report
Page 3
EXECUTIVE SUMMARY
The North East Thames Regional Genetics Service has continued to increase overall activity during the year. General clinic appointments were 11% above baseline, with cancer appointments just below baseline. Cytogenetics and molecular genetics laboratory activity rose significantly by 36% and 7% respectively; much of which was driven by the introduction of chromosomal microarray analysis as a first line test for all referrers. Cancer samples processed by the molecular genetics laboratory showed an increase of 31% above baseline.
2010-2011 has been a year of significant organisational change for the Service with the move of the Clinical department to York House (now co-located with the laboratories) and the transfer to electronic records. The Service continues to develop new clinics, new cytogenetic and molecular tests and new methods to improve workflows and efficiencies. The cytogenetics laboratory has benefitted from the automation of cell harvesting, slide making, staining and cover slipping. The molecular genetics laboratory has further expanded its test portfolio, following the successful approval of a number of gene dossier applications to the UK Genetic Testing Network. In April 2010, a new Great Ormond Street Hospital led NCG service for Bardet-Biedl syndrome was introduced with partner centres at Guy’s Hospital and Birmingham Children’s Hospital.
Following the re-organisation in 2009-2010, the laboratories have continued to build on the new structures with integrated administrative, clerical, business and IT support functions across both laboratories. Translational research and development, new technologies and new service developments have been a major focus during the year with help from infrastructure investment and successful grant funding. Emma Ashton received a NIHR CSO Healthcare Scientist Fellowship to develop clinical applications of next generation sequencing and our R&D programme was further boosted by the acquisition of a bench top next generation sequencer. The laboratory has further enhanced its expertise in the analysis of cell free fetal DNA with a number of peer-reviewed publications and presentations at national and international meetings and the NIHR RAPID (reliable accurate prenatal non-invasive diagnosis) project held a number of dissemination meetings and laboratory workshops.
Education and training remain a key activity with the clinical team hosting numerous clinical trainees and visitors and the laboratories continuing to participate in the Department of Health pilot scheme for Modernising Scientific Careers with two scientists appointed to the Scientist Training Program (STP) and one to the Practitioner Training Program (PTP).
Dr Angela Barnicoat Dr Nick Lench Lead Clinician Director, Genetics Laboratories
North East Thames Regional Genetics Service Annual Report
Page 4
1. INTRODUCTION
The NE Thames Regional Genetics Service at Great Ormond Street Hospital comprises the Clinical Genetics Department and the Laboratories for Cytogenetics and Molecular Genetics and is commissioned to provide a service to a population of approximately 4.5 million people including the whole of the North East of London and extends as far as Hertfordshire to the North and Essex to the South and East. The Unit also receives nationally commissioned funding for a number of specialised services including Bardet-Biedl syndrome, craniosynostoses, lysosomal storage disorders and severe combined immunodeficiencies. The laboratories provide an extensive range of diagnostic testing services and have full clinical pathology accreditation (CPA) status. The service is a member of the South East of England Genetics Network (SEEGEN) and the United Kingdom Genetics Testing Network (UKGTN).
Research and development is a key objective of the Unit, a number of staff having joint academic appointments with University College London. The service has a strong commitment to education and training and public and patient engagement and participates in clinician, scientist and technologist training programmes. A number of staff are also actively involved at a regional and national level in policy development, training and examination.
North East Thames Regional Genetics Service Annual Report
Page 5
2. CLINICAL GENETICS
The Clinical Genetics service is headed by Dr Angela Barnicoat. Ten consultant staff provide a total of 70 weekly sessions across a range of general, cancer and specialist clinics. The department benefitted from the appointment of two new consultant staff in September 2010. Dr Jane Hurst joined the department from the Oxford Regional Genetics Service working 0.8 FTE with Dr Richard Scott being appointed from the Thames Training Scheme working full time with a 0.2 FTE academic commitment. Dr Adam Shaw left the Service in spring 2010.
The Clinical Nurse Specialists and Genetic Counsellors team has a total of 8 staff providing a total of 5.8 FTEs. Kelly Loggenberg joined the department replacing Chris Harocopos on her retirement. The majority of general and cancer clinic appointments are held at local hospitals, with only a small number of home visits provided. The genetic counsellors control their own case-load and manage a significant proportion of prenatal diagnoses handled by the department. The Service is supported by a team of administrative staff. During the year the service underwent a major change transferring from paper records to electronically held notes with consequent reconfiguring of departmental processes leading to a restructuring of administrative posts and duties. Chris Skilbeck was appointed as a six month project manager for this work. The administrative staff complement is now a Band 5 office manager, three Band 4 secretarial posts and three Band 3 administrative support posts. Jacqueline Cross (secretary) and Michael James (IT and data support) long serving members of the administrative team, retired during the year. The IT support post was subsumed into other administrative roles.
2.1. Staff List Clinical Geneticists and Consultant
Academic Staff
Angela Barnicoat Lead Clinician
Maria Bitner-Glindzicz Consultant and Reader, Clinical and Molecular Genetics, ICH
Jane Hurst Consultant and Dysmorphology Lead
Ajith Kumar Consultant
Melissa Lees Consultant
Alison Male Consultant
Elisabeth Rosser Consultant
Richard Scott Consultant and Honorary Senior Lecturer, ICH
Lucy Side Consultant, Senior Lecturer UCL, Lead Cancer Genetics Service
North East Thames Regional Genetics Service Annual Report
Page 6
Louise Wilson Consultant
Phil Beales Professor, Molecular Medicine, ICH
Lyn Chitty Professor, Genetics and Fetal Medicine, ICH
Gudrun Moore Professor, Clinical and Molecular Genetics, ICH
Clinical Nurse Specialists and
Genetic Counsellors
Cheryl Berlin The Royal Free Hospital
Anita Bruce South Essex
Bernadette Farren Great Ormond St Hospital
Christina Harocopos* Bart’s and The London Hospital
Ella Hillbehari Homerton Hospital
Kelly Loggenberg Bart’s and The London Hospital
Kate Simon South Essex
Sally Taffinder Great Ormond St Hospital and UCLH
Emma Williams Great Ormond St Hospital
Administrative and Clerical Staff
Chris Skilbeck Project Manager
Nasrin Khalique Office Manager
Jacqueline Charles Secretary
Jill Corneille Secretary
Jacqueline Cross* Secretary
Michael James* Data and IT Manager
Elizabeth Sturges Data Entry Clerk
Temporary Staff (2.0 FTE) Administrative Support
*Staff Leavers 2010-2011
North East Thames Regional Genetics Service Annual Report
Page 7
2.2. General Clinics
General clinics are held at several sites across the region. Most referrals for families with known inherited conditions or for children with developmental problems are offered appointments at their local clinic. Urgent referrals are dealt with locally at Great Ormond Street Hospital or University College London Hospital (UCLH). Clinics at UCLH are held at the Fetal Medicine Unit and are generally for ongoing pregnancies requiring intervention. There is a daily ward review service at Great Ormond Street Hospital, ward reviews are offered at peripheral sites where clinics are held if the visiting geneticist is available on site.
2.3. Cancer Clinics
The service provides a broad service for general cancer referrals as well as specialist expertise in paediatric, syndromic and neuroendocrine cancers. The service is supported by five genetics counsellors (representing 3.8 FTEs) and covers three major cancer networks: North London, North East London and Essex.
Face to face clinics are held at Great Ormond Street, The Royal Free, Bart’s and The London and University College London hospitals as well as in four regional hospitals in Essex.
The common cancers with a significant genetic pre-disposition are stratified into three risk levels (high, medium, population average) based on family history. Patients and families with rare or syndromic cancers are managed by the consultants. Dr Elisabeth Rosser provides two sessions a week to the Supra-regional Retinoblastoma service at Bart’s and The London Hospital. The service actively identifies patients for recruitment to national cancer clinical trials.
Specialist Cancer Clinics
Neuroendocrine Bart’s and The London
Retinoblastoma Supra-regional Service, Bart’s and The London
Von-Hippel Lindau The Royal Free Hospital
2.4. Specialist Clinics
The service also operates a number of specialist clinics across the region. Clinics held at Great Ormond Street Hospital include the Dysmorphology Clinic led by Dr Jane Hurst and Dr Richard Scott. Dr Maria Bitner-Glindzicz provides a genetic deafness clinic at Great Ormond Street Hospital and a dual sensory impairment clinic at the National Hospital for Neurology and Neurosurgery. The Neurogenetics Clinic at the National Hospital for Neurology and Neurosurgery focuses mainly on patients with Huntington’s disease; patients requesting predictive testing are seen by Dr Elisabeth Rosser.
North East Thames Regional Genetics Service Annual Report
Page 8
Specialist Clinics
Cardiac Genetics The London Chest Hospital
Regional Cleft Lip and Palate Great Ormond St Hospital and The Broomfield Hospital
Deafness The Nuffield Hospital
Dual Sensory Impairment National Hospital for Neurology and Neurosurgery
Di George Syndrome Great Ormond St Hospital
Dysmorphology Great Ormond St Hospital
Endocrine and Urology Great Ormond St Hospital
Neurogenetics National Hospital for Neurology and Neurosurgery
2.5. Activity General clinic appointments were 11% above baseline level in 2010-2011, cancer clinics appointment decreased by 6%.
Non-Cancer Clinic Appointments 2010-2011
Region Baseline Actual
Bedfordshire and Hertfordshire
151 157
Essex 1039 1138
North West London 152 123
North Central London 685 727
North East London 920 1166
South East London 50 30
South West London 54 57
Kent and Medway 37 40
Surrey and Sussex 55 53
Total 3143 3491
North East Thames Regional Genetics Service Annual Report
Page 9
Cancer Clinic Appointments 2010-2011
Region Baseline Actual
Bedfordshire and Hertfordshire
62 34
Essex 612 546
North West London 31 21
North Central London 384 385
North East London 409 439
South East London 18 10
South West London 5 5
Kent and Medway 13 3
Surrey and Sussex 5 3
Total 1539 1446
We continue to monitor and seek ways to improve Failure to Attend (FTA) rates. Services continue to be offered in areas with high social deprivation including some with high transient refugee populations. Communication with patients can be challenging - interpreters are often required and many families are relocated during the time between referral and appointment.
2.6. Transfer from Paper Records to Electronic Notes The clinical department relocated from Long Yard to Level 4 of York House on the Great Ormond Street Hospital site in November 2010. This was needed because of other changes within the Trust and ICH but was an opportunity to become co-located with the Genetics Laboratories (on levels 5 and 6 of York House) and allows further integration of the services. As the new space did not have room for the paper notes it was an opportunity to modernise our storage to an electronic format and along with this develop new digital processes. The move was accomplished without any loss of clinic time or activity. At the same time all the old notes were digitised into a searchable PDF format. These records along with newly created ones are now stored in a secure part of the clinical documents database held at GOSH. New processes for dealing with referrals, and incoming and outgoing post, in an electronic format were designed and implemented. Clinicians delivering services at peripheral sites have been supplied with laptops that can link to Great Ormond Street securely via the mobile network so that records can be safely used when offsite. There are numerous benefits to the new way of working along with some challenges – we are continuing to improve and streamline the systems.
North East Thames Regional Genetics Service Annual Report
Page 10
2.7. Universal Newborn Screening Service – Cystic Fibrosis Currently Great Ormond Street Hospital carries out a new born baby screening support service for the whole of London. It has been delivering this service for almost 4 years. The genetic counsellor who delivers this work receives the results of the blood spot tests from 3 different laboratories. The information received confirms the baby’s genetic results and the mother’s name and GP. The clinical work this generates can be quite considerable: throughout the genetic counsellor is overseeing the process and ensuring the right steps are happening to time. Records of individual family contact are documented and records of the activity levels stored. The service provides a single point of contact for the laboratories. The use of an experienced genetic clinical nurse specialist means that a high quality service is delivered with attention to detail and appropriate levels of support and reassurance.
2.8. Patient and Public Involvement 2.8.1. Genetics for Interpreters In May 2010, two courses in Genetics for Interpreters were run by Dr Elisabeth Rosser. These training days arose from discussions with Language Line who provide interpreting services for our clinics. We wanted to provide information to the interpreters about the service, what would happen during the appointment and on the different modes of inheritance. Over 60 interpreters and health advocates attended the two sessions, mainly from Language Line, but also from GOSH and The Royal London Hospital. Over 30 languages were represented from Albanian to Vietnamese. The sessions ended with a workshop-based discussion on difficult scenarios. Feedback was extremely positive.
2.8.2. Patient Survey This was carried out in May 2010; 369 surveys were sent out, including, for the first time, some in other languages. 77 completed surveys were returned, a further 25 partial surveys were returned. In general, patient satisfaction with the service was very high with:
• 84/85 people saying that the appointment was helpful
• 86/86 saying that they understood some or all of what they were told in the appointment
• 76/76 said that the letter they received after the clinic was easy to understand
• 81/87 said that they had been given all the information that they needed
• 83/84 felt they had been treated with respect.
2.8.3. Patient Information Evening - “Telling the Family about a Genetic Disorder” A patient information evening entitled “Telling the Family about a Genetic Disorder” was held. An invitation to the evening was sent out with every letter to patients from the beginning of March. Approximately 35 people attended the evening. Speakers came from within and outside of the Genetics Department and there were sessions on basic genetics and different modes of inheritance, is there a right time to convey genetic information, the role of patient organisations, talking to adolescents, guidelines for testing children and the communication of genetic risk; feedback was very positive.
North East Thames Regional Genetics Service Annual Report
Page 11
2.9. Training and Teaching
Clinical Genetics Trainees
Neeti Ghali
Janna Kenny
Helen Moody
Richard Scott
Shereen Tadros
A survey of the genetics training across the London centres was undertaken in 2010 London. The JCHMT national survey reported excellent and high quality training in Clinical Genetics in London. Formal training for Trainee Geneticists is held within the London Deanery in the form of 2 day Summer and Winter Schools. The Department hosted a 1 day of “Cardiology and Genetics” as part of this programme, where the London trainees in addition to trainees from other centres in the South of England including Cambridge and Southampton attended a day of guest and internal speakers, including a junior dysmorphology club.
Visitors
Dr Naomi Gerson-Sofer April 2009-present
Dr Caroline Daelemans April 2010
Dr Anna Kenyon April-September 2010
Neeti Lakhani April 2010
Tharsika Karunakaran April2010
Dr Salem El-Shawarby May 2010
Rosi Marsh May 2010
Anne McKirdy May-June 2010
Peishan Lee July 2010
Dr Gautam Ambegaonkar July-August 2010
Dr Alison Stellman August 2010
North East Thames Regional Genetics Service Annual Report
Page 12
Lisa Campisi September 2010
Sabrina Talukdar October 2010
Puja Mistry October 2010
Win Win Khine October-November 2010
Devesh Shah October-November 2010
Dr Kerry Robinson November 2010
Jonathan Payne November 2010
Dr Imelda Balchin December 2010-January 2011
Shahana Chowdhury December 2010
Dr Claudia Santoro January-July 2011
Dr Verity Harthill January 2011
Claire Giffney January-April 2011
Mike Paul-Smith January-February 2011
Miraim Schmidts January-February 2011
Dr Ruth Seager February 2011
Eva Karampetsou March 2011
Dr Divya Pore March-April 2011
Ji Soo Kim March-April 2011
The department undertakes a wide range of teaching activities, contributing to the medical undergraduate course at University College London and providing extensive postgraduate and health professional teaching within the department and at local NHS Trust sites. Teaching is offered to GP trainees and district hospitals in paediatric, obstetric and adult genetics. The department provides teaching for the Clinical Pediatrics MSc, Institute of Child Health. Informal teaching was also carried out in schools under the Jeans for Genes initiative. Highlights of formal teaching this year included:
• Clinical Genetics - What Does the Future Hold? August 2010
• Institute of Maternal and Child Health Medical College, Calicut, India
North East Thames Regional Genetics Service Annual Report
Page 13
• Manchester Dysmorphology Conference October 2010
• Skeletal Dysplasias: A Clinical Approach Skeletal Dysplasia Group Spring Instructional Course, Oxford
The department also provided a significant amount of informal teaching to observers sitting in on clinics over the course of the year. Local consultants and registrars regularly attend peripheral clinics as well as Fetal Medicine Unit trainees, GOSH and UCLH junior staff from other specialties and laboratory staff wanting to learn about the clinical service. The department also provides taster weeks for F1 and F2 trainees – a clinic visit is often a starting point for junior doctors and medical students who wish to consider clinical genetics as a career option.
2.10. Professional Duties Selected Responsibilities
Angela Barnicoat Forum for Clinical Effectiveness, Royal College of Physicians - CGS Representative
Clinical Governance Committee, CGS
Fragile X Syndrome Society, Specialist Advisor
Maria Bitner Glindzicz SENSE, Medical Advisor
Jeans for Genes Small Grants Panel
Deafness Research UK, Medical Advisor
RNID Research Grants Advisory Panel, Member
Human Tissue Act Licence for Research, ICH Representative
Anita Bruce AGNC Committee Member
AGNC Webmaster
Melissa Lees Pre-implantation Genetic Diagnosis Clinical Group, Clinical Advisor
Alison Male Smith-Magenis Foundation, Medical Advisor
Elisabeth Rosser Secretary, CGS
Retinoblastoma Society, Research Committee Member
National Organisation for Fetal Alcohol Syndrome, Trustee
Lucy Side BSHG Scientific Committee Member for Conference
North East Thames Regional Genetics Service Annual Report
Page 14
Steering Group Member Cancer Genetics Group BSHG
Genetics representative North London Cancer Network Tumour Board
Advisor Cancerkin Charity
London Genetics Consortium Advisory Group for Familial Breast Cancer Management
Sally Taffinder Antenatal Results and Choices, Trustee
Louise Wilson Skeletal Dysplasia Group, CGS Representative
North East Thames Regional Genetics Service Annual Report
Page 15
3. REGIONAL GENETICS LABORATORIES
Management
Nick Lench PhD FRCPath Director Joint Laboratories and Honorary Reader, ICH
Jon Northfield Admin and Finance Manager
Mike Tinsley IT and Data Analyst Specialist
Gillian Hendry Secretary and Office Administrator
Bola Olayinka Administrator
Tony Paul Administrator
Fatima Sonowar Administrator
Donna Thomas* Administrator
Research Staff
Angela Barrett PhD Post-doctoral Scientist, RAPID Project
Suzie Drury PhD Post-doctoral Scientist, Translational Research
Tom McDonnell Research Assistant, RAPID Project
Darrell Wang* Research Assistant, RAPID Project
*Staff Leavers 2010-2011
3.1. Cytogenetics Service Staff List
Cytogenetics Staff 2010-2011
Jonathan Waters PhD FRCPath Head of Service, Deputy Director, Joint Laboratories and Honorary Lecturer, ICH
Ann Jackson FRCPath Head of Section - Clinical Scientist
Rodger Palmer Head of Section - Clinical Scientist
Tom Spencer Head of Section - Clinical Scientist
Tracey Adams* Registered Clinical Scientist
Lee Grimsley Registered Clinical Scientist
North East Thames Regional Genetics Service Annual Report
Page 16
Deborah Morrogh DipRCPath Registered Clinical Scientist
Lucy Platts Registered Clinical Scientist
Denise Rooney PhD Registered Clinical Scientist
Rubin Wang PhD Registered Clinical Scientist
Qian Zheng Registered Clinical Scientist
Kamila Jagiello Registered Clinical Scientist
Paula Stubbs Registered Clinical Scientist
Jo Gilmore Pre-registration Clinical Scientist
Monika Augustynowicz Pre-registration Clinical Scientist
Drew Ellershaw Trainee Clinical Scientist
Tanja Fiegel Trainee Clinical Scientist
Jennifer Carter Trainee Clinical Scientist
Evangelia Karempetsou Trainee Clinical Scientist
Olivera Spasic-Boskovic Trainee Clinical Scientist
Celia Brown Scientist Trainee (Modernising Scientific Careers)
Rebecca Franses Scientist Trainee (Modernising Scientific Careers)
Harvinder Bangar Cytogenetic Technologist
Olugbenga Bashorun Cytogenetic Technologist
Eleanor Challis Cytogenetic Technologist
Christine Davies* Cytogenetic Technologist
Ahinora Dimitrova Cytogenetic Technologist
Anisa Jimalle Cytogenetic Technologist
Audrey Koomson* Cytogenetic Technologist
Nomfuneko Nosilela Cytogenetic Technologist
Karolina Pawliczak Cytogenetic Technologist
Claire Pearce Cytogenetic Technologist
North East Thames Regional Genetics Service Annual Report
Page 17
Remben Talaban Cytogenetic Technologist
John Lane Laboratory Assistant
*Staff Leavers 2010-2011
3.2. Cytogenetics Service Activity
Workload activity for the Genetics Consortium showed a major increase during 2010-2011, with a 36% rise in total workload units against baseline. This increase in activity was a direct result of the introduction of chromosomal microarray analysis as a first line test for children with multiple congenital anomalies, developmental delay and mental retardation. Sample turnaround times were within the defined national targets, with the exception of routine bloods.
Genetics Consortium Activity 2010-2011 Work Load Units
Chromosomal microarray 3435
Bloods 4404
FISH 393
Solid tissues 481
Chorionic villus 591
Amniotic fluid 429
TOTAL 9733
Turnaround Times 2010-2011 Days to
Report
National Target
Bloods 61.9 30.3
Urgent bloods 5.9 7.4
Solid tissues 21.8 29.2
Chorionic villus 10.3 12.1
Amniotic fluid 11.5 12.0
North East Thames Regional Genetics Service Annual Report
Page 18
3.3. New Service Developments 3.3.1. Chromosomal Microarrays The diagnostic yield for CMA (~15%) continues to be significantly higher than for karyotyping. In January 2011 chromosomal microarray (CMA) analysis was made available as a first line test for appropriate referrals from all departments at Great Ormond Street Hospital and subsequently in March 2011 to all users across the NE Thames region. This represents a major transformation in our diagnostics provision and has removed the need for clinicians to refer patients and their families via Clinical Genetics for microarray analysis; this has resulted in a significant improvement in the patient testing pathway. The majority of samples received for testing are now analysed by chromosomal microarray.
3.3.2. Automation of Cell Harvesting, Slide Making and Staining Over the course of 2010-2011, the laboratories have procured four new pieces of equipment to enable semi-automation of the cell harvesting, slide making and staining process. These will help streamline the workflow and provide more consistency and reproducibility to chromosome preparations.
3.3.3. Solid Tissue Analysis 2010-2011 was the first full year for which a combined quantitative fluorescent PCR (QF-PCR) and multiplex-ligation dependent primer amplification (MLPA) service was offered for all pregnancy loss samples. The replacement of karyotyping with QF-PCR and MLPA has led to the dual benefit of significantly improved success rates (increasing from 83% to 94%) and reduced reporting times (21 days to 12 days).
3.4. Quality The laboratory completed the appropriate paperwork, clearing non-compliances, to maintain full accreditation following a CPA surveillance visit in February 2011.
The laboratory participated in the Cytogenetics UKNEQAS scheme including a chromosomal microarray pilot scheme and in a London Region External Quality Assessment scheme for solid tissue investigation using MLPA.
The laboratory also successfully applied for and gained UKGTN registered laboratory status.
The laboratory successfully migrated to the Q-Pulse Quality Management Software. This software package is used by the Molecular Genetics laboratory and other Pathology laboratories within Great Ormond Street Hospital. This will further the operational integration of the cytogenetics and molecular genetics laboratories.
North East Thames Regional Genetics Service Annual Report
Page 19
3.5. Molecular Genetics Service Staff List Molecular Genetics Staff 2010-2011
Lucy Jenkins FRCPath Head of Service
Sam Loughlin DipRCPath Deputy Head of Service
Emma Ashton PhD DipRCPath Head of Section - Clinical Scientist
Ann-Marie Differ Head of Section - Clinical Scientist
Fiona McKay DipRCPath Head of Section - Clinical Scientist
Alison Taylor DipRCPath Head of Section - Clinical Scientist
Clare Beesley PhD Registered Clinical Scientist
Shahnaz Bibi DipRCPath Registered Clinical Scientist
Cathy Meaney Registered Clinical Scientist
Sam McCall* DipRCPath Registered Clinical Scientist
Valerie Witt PhD Registered Clinical Scientist
Sarah Fielding Pre-Registration Clinical Scientist
Bethan Hoskins PhD Pre-Registration Clinical Scientist
Natalie Trump PhD Pre-Registration Clinical Scientist
Kunjan Patel Trainee Clinical Scientist
Leesa Morris Practitioner Trainee (Modernising Scientific Careers)
Lighta Godinho DNA Preparation Laboratory Manager
Brendan Martin Senior Medical Technical Officer
Solmaz Oskooei Senior Medical Technical Officer
Neesa Bhudia Medical Technical Officer
Toulla Hoskins Medical Technical Officer
Tom Linton-Willoughby Medical Technical Officer
Bhaneeta Mistry Medical Technical Officer
Louisa Steel Medical Technical Officer
Lech Stepkowski Medical Technical Officer
North East Thames Regional Genetics Service Annual Report
Page 20
Joseph Tsedeke Medical Technical Officer
*Staff Leavers 2010-2011
3.6. Molecular Genetics Service Activity
Commissioned activity increased significantly during the year with a 7% and 31% rise above baseline for non-cancer genetic testing and cancer genetic testing respectively. Total laboratory activity also increased, a significant proportion of which includes NCG service activity for Bardet-Biedl syndrome, craniosynostoses, immunodeficiencies and lysosomal storage diseases.
Samples 2010-11 Number
Samples received 12439
Samples extracted 10649
Samples exported 2862
Reports Issued 2010-11 Number
Deafness 1226
Fragile X 1081
Cystic fibrosis 591
Cardiac genetics 638
Metabolic disease 460
Immunodeficiencies 407
Craniosynostoses 385
Imprinting disorders 190
Free fetal DNA analysis 103
Other 321
*TOTAL 5402
*Excluding Store Letters
North East Thames Regional Genetics Service Annual Report
Page 21
3.7. New Service Developments Eight gene dossiers were submitted and approved by UKGTN enabling the laboratory to expand its UK wide services.
Gene Disorder
CFHR5 Glomerulonephritis
CYP1B1 Primary Congenital Glaucoma
KCNJ10 EAST syndrome
MLL2 Kabuki syndrome
RMRP Cartilage Hair Hypolplasia
SRY Fetal sexing using non-invasive prenatal diagnosis (NIPD)
PAX3 Waardenburg syndrome
TGFBR1 and TGFBR2 Loeys-Dietz syndrome
3.8. Quality
The laboratory participated in the Molecular Genetics UKNEQAS 2010 scheme for fragile X, connexin 26, cystic fibrosis, Angelman/Prader-Willi syndromes, MCADD and for testing for maternal cell contamination in prenatal samples. The laboratory participated in the European Molecular Genetics Quality Network (EMQN) for connexin 26 and in an Australian sample exchange scheme for familial hypercholesterolemia. The laboratory also regularly provides audit data for activity, reporting times and workforce details to GOSH NHS Trust, the London Genetics Consortium, the Clinical Molecular Genetics Society and the UK Genetic Testing Network.
3.9. Continuing Professional Development 3.9.1. Modernising Scientific Careers
The laboratories participated jointly in the Department of Health pilot scheme for Modernising Scientific Careers. Led by the Chief Scientific Officer, this key work programme has been created to ensure flexibility, sustainability and modern career pathways for the healthcare science workforce and fit to address the needs of the future NHS. In a joint application with the NW Thames Regional Genetics Service, Northwick Park, two scientists were appointed to the Scientist Training Program (STP). One Practitioner Training Program (PTP) trainee was recruited to GOS.
3.9.2. Teaching Staff contributed to various formal teaching programmes e.g. MSc courses in Fetal Medicine and Clinical Biochemistry (UCL) and an intercalated BSc course in Genetics for Paediatricians (ICH, UCL). Staff also hosted laboratory visits from students on these courses as well as visits from obstetrics trainees and midwives with the NE Thames region as part of their laboratory practice training requirements.
North East Thames Regional Genetics Service Annual Report
Page 22
3.9.3. Meetings Attended
Date Scientific and Clinical Meetings Location Attendees
April 2010 The Development of Laboratory Standards for Non-invasive Prenatal Diagnosis Workshop
ICH, London 4
April 2010 CMGS Annual Spring Conference 2010 Oxford 3
April 2010 ACC Annual Spring Conference 2010 Oxford 4
June 2010 Signature Genomics Scientific Microarray Conference
Spokane, USA
1
July 2010 International Society for Prenatal Diagnosis Amsterdam 4
September 2010
BSHG 2010 University of Warwick
8
October 2010
The UK Pharmacogenetics and Stratified Medicine Network Meeting
Genome Campus, Hinxton
1
November 2011
RAPID Project Dissemination Meeting ICH, London 4
November 2011
UKGTN Conference – QIPP Supporting Genetics Services
London 3
November 2011
Lipid X Update Meeting Stratford upon Avon
1
December 2011
Revolution in Gene Identification: Clinical Impact of New Technologies
ICH, London 3
January 2011
Paediatric Epilepsy Research Retreat Surrey 1
January 2011
National Audit of the Management of Familial Hypercholesterolaemia
London 1
January 2011
Eye Genetics Meeting Oxford 1
January 2011
Deciphering Developmental Disorders Research Forum
Genome Campus, Hinxton
2
North East Thames Regional Genetics Service Annual Report
Page 23
Date Training and Technology Meetings Location Attendees
June 2010 4th Roche Genome Sequencer FLX User Conference
Athens, Greece
1
July 2010 New Technologies Salisbury 2
July 2010 Modernising Scientific Careers – Train the Trainers
Birmingham 1
March 2011 NIHR Healthcare Science Advisory Group Meeting
London 1
March 2011 Unclassified Variants – Best Practice Guidelines London 1
Date Teaching - Course Location Lectures
UCL MSc, Fetal Medicine UCL, London 2
UCL MSc, Paediatrics UCL, London 2
UCL MSc, Human Genetics UCL, London 1
UCL MSc, Clinical Biochemistry UCL, London 1
Date Examination Location
UCL PhD Viva UCL, London 2
3.10. Professional Duties
Selected Responsibilities
Nick Lench National Genetics Reference Laboratories
Steering Committee
Nick Lench NIHR Programme Grant (RAPID project) Steering Group
Lucy Jenkins FRCPath Genetics, Course Facilitator
Lucy Jenkins CMGS Executive Committee
Lucy Jenkins UKNEQAS Steering Committee
Lucy Jenkins Assessor, Association of Clinical Scientists
Jonathan Waters RCPath Council
Jonathan Waters Chair, RCPath Specialist Advisory
North East Thames Regional Genetics Service Annual Report
Page 24
Committee, Genetics and Clinical
Embryology
Jonathan Waters RCPath Healthcare Science Curriculum
Committee
Jonathan Waters DH National Healthcare Genetics School Board
Jonathan Waters ACC/CMGS Genetics Education and
Training Board
Jonathan Waters BSHG Scientific Programme Committee
Ann Jackson Assessor, Association of Clinical Scientists
4. RESEARCH AND DEVELOPMENT
4.1. RAPID (Reliable accurate prenatal non-invasive diagnosis)
The service is working with Professor Lyn Chitty, UCL Institute of Child Health to further develop non-invasive prenatal diagnosis. The RAPID project is funded by a 5 year NIHR programme grant and the main aim of the study is to improve the quality of NHS prenatal diagnostic services by evaluating early non-invasive prenatal diagnosis (NIPD) based on cell free fetal (cff) DNA and RNA in maternal plasma.
4.1.1. Collection and Processing of Samples
Many of the key technical challenges associated with developing NIPD tests arise from the relatively low abundance (around 5-10%) and small fragment size of the fetal DNA. Consequently, it is critical to maximise the yield and quality of cffDNA at every step of the collection and processing pathway. This is particularly important in the UK where genetics services are distributed throughout the country and samples require transportation to central laboratories for analysis. The RAPID team at GOSH and UCLH have undertaken a study to explore various factors that might influence the yield of cffDNA by looking at the effect of 1) the time interval between maternal blood draw and separation of plasma, 2) blood storage temperature prior to preparation of plasma, and (iii) cell-free DNA.
4.1.2. Pilot EQA Scheme
A pilot EQA scheme for fetal sex determination was conducted in collaboration with UK NEQAS for Molecular Genetics and the National Genetics Reference Laboratory (Manchester). The pilot involved four laboratories that each tested 3 anonymised samples. The assessors gave feedback on report style and test results. An expanded pilot EQA scheme is being undertaken in 2011 as part of the Eurogentest 2, FP7 programme in collaboration with RAPID.
4.1.3. Free Fetal DNA Extraction Workshop
A free fetal DNA extraction workshop for all UK laboratories interested in NIPD has been completed. Thirteen laboratories from around the UK participated. The workshop had three objectives: 1)
North East Thames Regional Genetics Service Annual Report
Page 25
comparison of 3 DNA extraction kits; 2) comparison of SRY and DYS14 real-time PCR assays side by side; 3) comparison of real-time PCR and digital PCR.
4.1.4. Diagnosis of Single Gene Disorders
As part of the RAPID project we are developing NIPD for some single gene disorders. The ability to provide a definitive diagnosis both earlier in pregnancy and more safely by avoiding invasive tests will have significant benefits for parents. At present, NIPD for single gene disorders is limited to cases where an autosomal dominant mutation is carried on the paternal chromosome or has arisen de novo at conception. For autosomal recessive conditions, it is possible to determine if the fetus is at risk or not by detecting or excluding the paternal allele if the parents carry different mutations. The absence of the disease causing paternal mutation in the amplified cffDNA indicates that the fetus is not affected. Presence of the mutation will indicate that the fetus is at 50% risk and further testing is required to determine whether the maternal mutation has been inherited too. We are offering NIPD for some conditions on a research basis. Before more widespread implementation is possible, rigorous laboratory and clinical standards need to be developed. This is a major work theme of the RAPID Programme. To date we have successfully used NIPD in the diagnosis of some of the autosomal dominant genetic conditions that affect bone growth including:
• achondroplasia
• thanatophoric dysplasia
• Apert syndrome
4.2. Next Generation Sequencing
Emma Ashton was awarded a prestigious NIHR CSO Healthcare Scientist Postdoctoral Fellowship to develop diagnostic applications of next generation sequencing – this part time fellowship is funded for 4 years. The work will focus on the development and implementation of targeted re-sequencing approaches to diagnostic gene panels in a number of disease areas including nephrology, inherited cardiac conditions and severe combined immunodeficiencies. The laboratories have invested in the Fluidigm Access Array system for the generation of multiple amplicons for DNA sequencing in conjunction with the Roche GS Junior benchtop sequencer. The department has established collaborative links with UCL Genomics and GOSgene (http://www.ucl.ac.uk/ich/services/lab-services/gosgene) to facilitate the improved integration of translational activities.
4.3. Chromosomal Microarrays
A number of collaborative and in-house projects have focussed on the use of standard, high-density and custom microarrays to define specific chromosomal anomalies. These have included projects with the UCL Institute of Neurology investigating adult and childhood epilepsies, UCL Institute of Child Health (hyperinsulinaemia) and UCL Mental Health Sciences (schizophrenia).
Rubin Wang was awarded a CPA bursary to investigate the use of qPCR for the confirmation and follow up of chromosomal microarray findings.
North East Thames Regional Genetics Service Annual Report
Page 26
5. PUBLICATIONS, ABSTRACTS & PRESENTATIONS
Selected Publications Abbaszadeh F, Barker KT, McConville C, Scott RH, Rahman N. A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma. Fam Cancer. 2010; 9(3):425-430. Adalat S, Bockenhauer D, Ledermann SE, Hennekam RC, Woolf AS. Renal malformations associated with mutations of developmental genes: messages from the clinic. Pediatr Nephrol. 2010; 25(11):2247-2255. Epub 2010 Jul 6. Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res. 2010; 70(23):9742-9754. Epub 2010 Nov 30. Baple E, Palmer R, Hennekam RC. A microdeletion at 12q24.31 can mimic beckwith-wiedemann syndrome neonatally. Mol Syndromol. 2010; 1(1):42-45. Epub 2010 Jan 11. Belligni EF, Palmer RW, Hennekam RC. MECP2 duplication in a patient with congenital central hypoventilation. American Journal of Medical Genetics A. 2010; 152A(6):1591-1593. Bitner-Glindzicz M, Osei-Lah V, Colvin I, Sirimanna T, Lucas D, Mac Ardle B, Webb D, Shankar A, Kingston J, Jenkins L, Rahman S. Aminoglycoside-induced deafness during treatment of acute leukaemia. Arch Dis Child. 2010; 95(2):153-155. Brain CE, Creighton SM, Mushtaq I, Carmichael PA, Barnicoat A, Honour JW, Larcher V, Achermann JC. Holistic management of DSD. Best Pract Res Clin Endocrinol Metab. 2010; 24(2):335-354. Chitty LS, Griffin DR, Meaney C, Barrett A, Khalil A, Pajkrt E, Cole TJ. New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma. Ultrasound Obstet Gynecol. 2011; 37(3):283-289. Duff K, Paulsen J, Mills J, Beglinger LJ, Moser DJ, Smith MM, Langbehn D, Stout J, Queller S, Harrington DL; PREDICT-HD Investigators and Coordinators of the Huntington Study Group. Mild cognitive impairment in prediagnosed Huntington disease. Neurology. 2010; 75(6):500-507. Epub 2010 Jul 7. Engel C, Versmold B, Wappenschmidt B, Simard J, Easton DF, Peock S et al. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2010; 19(11):2859-2868. Epub 2010 Oct 26. Fassone E, Duncan AJ, Taanman JW, Pagnamenta AT, Sadowski MI, Holand T, Qasim W, Rutland P, Calvo SE, Mootha VK, Bitner-Glindzicz M, Rahman S. FOXRED1, encoding an FAD-dependent oxidoreductase complex-I-specific molecular chaperone, is mutated in infantile-onset mitochondrial encephalopathy. Hum Mol Genet. 2010; 19(24):4837-4847. Epub 2010 Sep 21. Frost JM, Monk D, Stojilkovic-Mikic T, Woodfine K, Chitty LS, Murrell A, Stanier P, Moore GE. Evaluation of allelic expression of imprinted genes in adult human blood. PLoS One. 2010; 5(10):e13556. Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, Daniels G, Chitty LS. Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet. 2011; 80(1):68-75. Epub 2010 Sep 15.
North East Thames Regional Genetics Service Annual Report
Page 27
Hill M, Taffinder S, Chitty LS, Morris S. Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England. Prenat Diagn. 2011; 31(3):267-273. Epub 2011 Jan 4. Isidor B, Pichon O, Redon R, Day-Salvatore D, Hamel A, Siwicka KA, Bitner-Glindzicz M, Heymann D, Kjellén L, Kraus C, Leroy JG, Mortier GR, Rauch A, Verloes A, David A, Le Caignec C. Mesomelia-synostoses syndrome results from deletion of SULF1 and SLCO5A1 genes at 8q13. Am J Hum Genet. 2010; 87(1):95-100. Epub 2010 Jun 17. Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG. 2011; 118(7):814-824. Meaney C, Norbury G. Non-invasive prenatal diagnosis. Methods Mol Biol. 2011; 688:155-172. Middleton A, Turner GH, Bitner-Glindzicz M, Lewis P, Richards M, Clarke A, Stephens D. Preferences for communication in clinic from deaf people: a cross-sectional study. J Eval Clin Pract. 2010; 16(4):811-817. Epub 2010 Jun 14. Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, Jameson C et al. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int. 2011; 107(1):28-39. Epub 2010 Sep 14. Nopoulos PC, Aylward EH, Ross CA, Johnson HJ, Magnotta VA, Juhl AR, Pierson RK, Mills J, Langbehn DR, Paulsen JS; PREDICT-HD Investigators Coordinators of Huntington Study Group (HSG). Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis. 2010; 40(3):544-554. Epub 2010 Aug 2. Osorio A, Milne RL, Alonso R, Pita G, Peterlongo P, Teulé A et al. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. Br J Cancer. 2011; 104(8):1356-1361. Epub 2011 Mar 22. Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB; Investigators of the European Huntington's Disease Network. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. PLoS Curr. 2010; Sep 28;2. pii: RRN1184. Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J et al. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2011; 103(2):105-116. Epub 2010 Dec 17. Raymond FL, Whittaker J, Jenkins L, Lench N, Chitty LS. Molecular prenatal diagnosis: the impact of modern technologies. Prenat Diagn. 2010; 30(7):674-681. Rooryck C, Diaz-Font A, Osborn DP, Chabchoub E, Hernandez-Hernandez V, Shamseldin H, Kenny J, Waters A, Jenkins D, Kaissi AA, Leal GF, Dallapiccola B, Carnevale F, Bitner-Glindzicz M, Lees M, Hennekam R, Stanier P, Burns AJ, Peeters, H, Alkuraya FS, Beales PL. Mutations in lectin complement pathway genes COLEC11and MASP1 cause 3MC syndrome. Nat Genet. 2011;43(3):197-203. Epub 2011 Jan 23. Shaw AC, van Balkom ID, Bauer M, Cole TR, Delrue MA, Van Haeringen A, Holmberg E, Knight SJ, Mortier G, Nampoothiri S, Pušeljić S, Zenker M, Cormier-Daire V, Hennekam RC. Phenotype and natural history in Marshall-Smith syndrome. Am J Med Genet A. 2010; 152A(11):2714-2726.
North East Thames Regional Genetics Service Annual Report
Page 28
Slade I, Bacchelli C, Davies H, Murray A, Abbaszadeh F, Hanks S et al. DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet. 2011; 48(4):273-278. Epub 2011 Jan 25. Slade I, Stephens P, Douglas J, Barker K, Stebbings L, Abbaszadeh F, Pritchard-Jones K; FACT collaboration, Cole R, Pizer B, Stiller C, Vujanic G, Scott RH, Stratton MR, Rahman N. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene. J Med Genet. 2010; 47(5):342-347. Epub 2009 Nov 30. Slatter MA, Angus B, Windebank K, Taylor A, Meaney C, Lester T, Norbury G, Hambleton S, Abinun M, Flood TJ, Cant AJ, Gennery AR. Polymorphous lymphoproliferative disorder with Hodgkin-like features in common γ-chain-deficient severe combined immunodeficiency. J Allergy Clin Immunol. 2011; 127(2):533-535. Epub 2010 Nov 20. Soneson C, Fontes M, Zhou Y, Denisov V, Paulsen JS, Kirik D, Petersén A; Huntington Study Group PREDICT-HD investigators. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis. 2010; 40(3):531-543. Epub 2010 Aug 2. Tan NH, Palmer R, Wang R. Evaluation of the efficacy of constitutional array-based comparative genomic hybridization in the diagnosis of aneuploidy using genomic and amplified DNA. J Obstet Gynaecol Res. 2010; 36:19-26.
Taylor A, Bayly G, Patel K, Yarram L, Williams M, Hamilton-Shield J, Humphries SE, Norbury G. A double heterozygote for familial hypercholesterolaemia and familial defective apolipoprotein B-100. Ann Clin Biochem. 2010; 47(5):487-490. Epub 2010 Aug 24. Taylor A, Wang D, Patel K, Whittall R, Wood G, Farrer M, Neely RD, Fairgrieve S, Nair D, Barbir M, Jones JL, Egan S, Everdale R, Lolin Y, Hughes E, Cooper JA, Hadfield SG, Norbury G, Humphries SE. Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin Genet. 2010; 77(6):572-580. Epub 2010 Mar 13. Turnbull C, Hines S, Renwick A, Hughes D, Pernet D, Elliott A, Seal S, Warren-Perry M, Gareth Evans D, Eccles D; Breast Cancer Susceptibility Collaboration UK, Stratton MR, Rahman N. Mutation and association analysis of GEN1 in breast cancer susceptibility. Breast Cancer Res Treat. 2010; 124(1):283-288. Epub 2010 May 30. Vandersteen AM, Hennekam RC. Mental retardation, premature balding, small genitalia, small acra and small patellae in brothers: confirmation of an entity. Eur J Med Genet. 2010; 53(5):314-317. Epub 2010 Jul 30. Van Esch H, Rosser EM, Janssens S, Van Ingelghem I, Loeys B, Menten B. Developmental delay and connective tissue disorder in four patients sharing a common microdeletion at 6q13-14. J Med Genet. 2010; 47(10):717-720. Epub 2010 Aug 3. Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L et al. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Hum Mol Genet. 2010; 19(14):2886-2897. Epub 2010 Apr 23.
North East Thames Regional Genetics Service Annual Report
Page 29
Whitaker HC, Kote-Jarai Z, Ross-Adams H, Warren AY, Burge J, George A et al. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS One. 2010 ; 5(10):e13363.
Selected Presentations
April 2010
CMGS/ACC Meeting, Oxford
Fielding S. Proof of Principle for the Non-Invasive Prenatal Diagnosis of Fetal Trisomy 21. Spasic-Boskovic, O. Evaluation of the use of 4x44K CytoChip – Oligo arrays for the diagnosis of constitutional imbalances.
June 2010
Signature Genomics Scientific Microarray Conference, Spokane, USA
Lench N. Diagnostic experience with a high resolution, high throughput array CGH platform (NimbleGen 12x135K). Lench N. Multiplex Ligation-Dependent Probe Amplification (MLPA) or Array CGH: Reliable and Cost Efficient Alternatives for Fetal Chromosome Analysis? September 2010
The British Society of Human Genetics Annual Meeting, Warwick
Palmer R. An approach to the analysis of aCGH data from multiplex microarray platforms in a clinical laboratory setting using the InfoQuant CGH Fusion and oneClickCGH software packages. October 2010
Manchester Dysmorphology Conference
Hurst J. The clinical features of Frank-Ter Haar syndrome in 5 children from the same family.
Beales P, Lees M. Identification of 3MC syndrome genes reveals a novel role for complement pathway components in development and disease.
November 2010
Fluidigm European Roadshow, London
Fielding S. Improved first level screening for autosomal dominant hypercholesterolaemia using the Fluidigm BiomarkTM platform.
North East Thames Regional Genetics Service Annual Report
Page 30
Selected Abstracts September 2010
The British Society of Human Genetics Annual Meeting, Warwick
Barrett, Chitty. Improving non-invasive prenatal determination of fetal sex; a comparison of two DNA extraction methods. Compton, Hill, Lewis, Morris, Chitty. Non-invasive prenatal diagnosis of single gene disorders: an exploration of views and preferences gathered from people who will use these tests. Differ, Patel, Bitner-Glindzicz, Lench, Jenkins. Testing for digenic inheritance in SCL26A4 heterozygotes. Fielding, Taylor, Jenkins, Lench. Improved first level mutation screening for autosomal dominant hypercholesteroleamia using the Fluidigm BioMark platform. Fielding, Taylor, Patel, Bayly, Waise, Luvai, Norbury, Humphries, Jenkins, Lench. Identification of two patients who are double heterozygotes for familial hypercholesterolaemia and familial defective apolipoprotein B-100. Hill, Taffinder, Finning, Martin, Hogg, Meaney, Daniels, Morris, Chitty. Non-invasive prenatal diagnosis for fetal sex in clinical practice: accurate information, fewer invasive tests and no additional health care costs. McKay, Jenkins, Bitner-Glindzicz, Lench. Development of a molecular genetic diagnostic service for Waardenburg syndrome Type1 and Type 3. Meaney, Barrett, Chitty. Non-invasive prenatal diagnosis of single gene disorders: an aid to the confirmation of fetal ultrasound findings. Palmer, Lees, Morrogh, Shaw, Wang, Waters. Further evidence of overgrowth and craniosynostoses in the chromosome 9q22 microdeletion syndrome. Patel, Taylor, Gilmour, Cale, Jenkins, Lench. A diagnostic service for X-linked hyperproliferative syndrome type 2. Shaw, Palmer, Barnicoat, Bitner-Glindzicz, Kumar, Male, Waters, Lees, Chitty. Array CGH in patients with cleft lip and/or palate. White, Dent, Hall, Crolla, Chitty. Facilitating implementation of NIPD: a modified protocol to detect the universal fetal DNA marker RASSF1A. Williams, Bruce, Side, Rosser. Provision of support within a regional genetics service for BRCA carriers: results from a patient information evening. July 2010
15th International Conference on Prenatal Diagnosis and Therapy, Amsterdam
Barrett, Zimmermann, Wang, Holloway, Chitty. Implementing non-invasive prenatal diagnosis into clinical practice: how should maternal blood be taken and prepared?
North East Thames Regional Genetics Service Annual Report
Page 31
Chitty, Akolekar, Levett, Kistler, Liddle, Nicolaides, Ballif, Shaffer. MLPA or aCGH: reliable, cost-efficient alternatives for fetal chromosome analysis? Hill, Taffinder, Norbury, Chitty, Morris. Non-invasive prenatal diagnosis of fetal sex: impact on clinical practice, costs and cost-effectiveness. Lench, Meaney, Barrett, Chitty. Implementing non-invasive prenatal diagnosis into clinical practice: impact on pregnancy management.
North East Thames Regional Genetics Service Annual Report
Page 32
NORTH EAST THAMES REGIONAL GENETICS SERVICE
Cytogenetics Laboratory Molecular Genetics Laboratory Clinical Genetics Level 5 Level 6 Level 4 York House York House York House 37 Queen Square 37 Queen Square 37 Queen Square London London London WC1N 3BH WC1N 3BH WC1N 3BH
[email protected] [email protected] 020-7829-8870 020-7762-6888 020-7762-6845